T1	Premise 845 1043	There was no statistically significant QOL difference between treatment in the combined community locations relative to hospital (difference of -7.2, 95% confidence interval: -19·5 to +5·2, P=0.25).
T2	Premise 1044 1163	There was a significant difference between the two community locations in favour of home (+15·2, 1·3 to 29·1, P=0.033).
T3	Premise 1259 1332	There was no evidence that community treatment compromised patient safety
T4	Premise 1337 1442	no significant difference between treatment arms in terms of overall costs or Quality Adjusted Life Year.
T5	Premise 1443 1662	Seventy-eight percent of patients expressed satisfaction with their treatment whatever their location, whereas 57% of patients preferred future treatment to continue at the hospital, 81% at GP surgeries and 90% at home.
T6	Claim 1864 1949	Patient QOL favours delivering cancer treatment in the home rather than GP surgeries.
T7	Claim 1950 2124	Nevertheless, both community settings were acceptable to and preferred by patients compared with hospital, were safe, with no detrimental impact on overall health-care costs.
R1	Support Arg1:T2 Arg2:T6	
R2	Support Arg1:T1 Arg2:T7	
R3	Support Arg1:T3 Arg2:T7	
R4	Support Arg1:T4 Arg2:T7	
R5	Support Arg1:T5 Arg2:T7	
